Poseida Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Poseida Therapeutics

10/11/2022 21:44

* Poseida Therapeutics Inc  PSTX.OQ  reported quarterly
adjusted
earnings of 92 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 65 cents per share.
    * Revenue was $116.31 million​; analysts expected $983.75
thousand. 
    * Poseida Therapeutics Inc's reported EPS for the quarter
was 92
cents​.
    * The mean earnings estimate of analysts had risen by
about 5.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Poseida Therapeutics Inc shares had risen by 22.1% this
quarter and lost 36.7% so far this year.
    * The company reported quarterly net income of $70.41
million.
    * Wall Street's median 12-month price target for Poseida
Therapeutics Inc is $16.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 09:44 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.65          0.92           Beat
 Jun. 30 2022      -0.76          -0.69          Beat
 Mar. 31 2022      -0.66          -0.93          Missed
 Dec. 31 2021      -0.35          0.02           Beat